期刊文献+

消痔灵注射液联合地奥司明治疗内痔51例疗效观察 被引量:1

Observation on the Effect of Xiaozhiling Injection Combined with Diosmin in the Treatment of 51 Cases of Internal Hemorrhoids
原文传递
导出
摘要 为观察消痔灵注射液联合地奥司明治疗内痔的疗效,将102例内痔患者随机分为对照组和观察组,每组51例。对照组患者采用消痔灵注射液治疗,观察组在对照组治疗的基础上口服地奥司明片治疗,比较2组患者的疗效、疼痛程度及炎症因子情况。结果显示,观察组患者总有效率为82.4%,对照组60.8%,2组比较差异有统计学意义(P<0.05)。观察组患者0级、Ⅰ级疼痛发生率均高于对照组(P<0.05),Ⅱ、Ⅲ级疼痛发生率均低于对照组(P<0.05)。治疗后2组患者TNF-α、IL-1β、IL-6、IL-8水平均低于治疗前,但观察组明显低于对照组(P<0.05)。结果表明,消痔灵注射液联合地奥司明可有效治疗内痔,缓解患者疼痛症状,降低炎症因子水平,有助于患者恢复。 In order to observe the curative effect of Xiaozhiling injection combined with Diosmin in the treatment of internal hemorrhoids(IH),102 patients with IH were randomly divided into control group(n =51,received Xiaozhiling injection)and observation group(n =51,received Diosmin tablets on the basis of the control group).The curative effect,pain degree and inflammatory factors of the two groups were compared.As results,the total effective rate was 82.4%in the observation group and 60.8%in the control group,there was statistical difference between the two groups(P<0.05).The incidence of grade 0 and gradeⅠpain in the observation group was higher than that in the control group(P<0.05),and the incidence of grade II and gradeⅢ pain in the observation group was lower than that in the control group(P<0.05).After treatment,the levels of TNF-α,IL-1β,IL-6,IL-8 in the two groups were lower than those before treatment,but the observation group was significantly lower than the control group(P<0.05).The results show that Xiaozhiling injection combined with Diosmin can effectively treat IH,relieve pain symptoms and reduce the level of inflammatory factors,which is helpful to the recovery of internal hemorrhoids.
作者 沈九龙 SHEN Jiu-long(Department of Pharmacy,Luoyang Central Hospital Affiliated to Zhengzhou University,Luoyang,Henan 471000)
出处 《中国肛肠病杂志》 2019年第10期44-45,共2页 Chinese Journal of Coloproctology
关键词 内痔 消痔灵注射液 地奥司明 Internal hemorrhoid Xiaozhiling Diosmin
  • 相关文献

参考文献2

二级参考文献10

  • 1欧阳钦.炎症性肠病的研究策略[J].中华消化杂志,2005,25(7):385-386. 被引量:8
  • 2痔临床诊治指南(2006版)[J].中华胃肠外科杂志,2006,9(5):461-463. 被引量:2128
  • 3Qin Ouyang,Rakesh Tandon,Khean-Lee Goh,Choon Jin Ooi,Haruhiko Ogata,Claudio Fiocchi.The emergence of inflammatory bowel disease in the Asian Pacific region[J].Current Opinion in Gastroenterology.2005(4)
  • 4Ito Hiroshi,Yamada Hidehiro,Shibata Toshiko N,Mitomi Hirofumi,Nomoto So,Ozaki Shoichi.Dual role of interleukin-17 in pannus growth and osteoclastogenesis in rheumatoid arthritis. Arthritis research & therapy . 2011
  • 5Davidson N J,Leach M W,Fort M M,Thompson-Snipes L,Kühn R,Müller W,Berg D J,Rennick D M.T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. The Journal of experimental medicine . 1996
  • 6N. J. Gullick,H. S. Abozaid,D. M. Jayaraj,H. G. Evans,D. L. Scott,E. H. Choy,L. S. Taams.??Enhanced and persistent levels of interleukin ( IL) ‐17<sup>+</sup> CD 4<sup>+</sup> T cells and serum IL ‐17 in patients with early inflammatory arthritis(J)Clin Exp Immunol . 2013 (2)
  • 7Siba P. Raychaudhuri.??Role of IL-17 in Psoriasis and Psoriatic Arthritis(J)Clinical Reviews in Allergy & Immunology . 2013 (2)
  • 8YangLIU,Roger Chun‐ManHO,AnselmMAK.??The role of interleukin (IL)‐17 in anxiety and depression of patients with rheumatoid arthritis(J)International Journal of Rheumatic Diseases . 2012 (2)
  • 9S.VERMEIRE.??Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease(J)Alimentary Pharmacology & Therapeutics . 2006
  • 10Atsuhiro Ogawa,Akira Andoh,Yoshio Araki,Tadao Bamba,Yoshihide Fujiyama.??Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice(J)Clinical Immunology . 2003 (1)

共引文献173

同被引文献10

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部